Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Kiromic Biopharma, Inc. (KRBP) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Executive Employment Agreement by and between Kiromic Biopharma, Inc. and Brian Hungerford"
10/02/2023 8-K Quarterly results
09/26/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/27/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form of the 25% Senior Secured Convertible Promissory Note"
07/25/2023 8-K Quarterly results
07/24/2023 8-K Quarterly results
07/19/2023 8-K Quarterly results
07/18/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
06/12/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/12/2023 8-K Other Events  Interactive Data
04/28/2023 8-K Quarterly results
03/31/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "KIROMIC BIOPHARMA, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES C CONVERTIBLE VOTING PREFERRED STOCK PURSUANT TO SECTION 151 OF THE",
"EXCHANGE AGREEMENT",
"KIROMIC BIOPHARMA, INC. 25% SENIOR SECURED CONVERTIBLE PROMISSORY NOTE AND SECURITY AGREEMENT"
03/17/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
03/10/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits ...
Docs: "CERTIFICATE OF AMENDMENT to the FOURTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION of KIROMIC BIOPHARMA, INC.",
"Kiromic BioPharma Announces Reverse Stock Split HOUSTON – Kiromic BioPharma, Inc. , a clinical-stage fully-integrated biotherapeutics company using its proprietary DIAMOND artificial intelligence and data mining platform to develop cell therapies with a focus on immune-oncology, announces that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-30 effective as of 4:01 p.m. Eastern Time today, March 10, 2023. Kiromic common stock will begin trading on a split-adjusted basis when the market opens on March 13, 2023 under the existing trading symbol KRBP. As a result of the reverse stock split, the CUSIP number for the Company’ s common stock will now be 497634204. The reverse stock split was previously approved by Kiromic stockholders at the Spec..."
03/07/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
02/27/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "KIROMIC BIOPHARMA, INC. 25% SENIOR SECURED CONVERTIBLE PROMISSORY NOTE AND SECURITY AGREEMENT"
01/26/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "NOTE PURCHASE AGREEMENT",
"."
12/30/2022 8-K Quarterly results
12/16/2022 8-K Quarterly results
12/12/2022 8-K Quarterly results
12/12/2022 8-K Quarterly results
11/30/2022 8-K Quarterly results
11/22/2022 8-K Quarterly results
11/04/2022 8-K Quarterly results
11/02/2022 8-K Quarterly results
10/27/2022 8-K Quarterly results
10/19/2022 8-K Quarterly results
10/14/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Stipulation of Settlement and Mutual Release, by and among Kiromic Biopharma, Inc., Empery Asset Master, Ltd. and other parties",
"Stipulation of Settlement and Mutual Release, by and among Kiromic Biopharma, Inc., Sabby Volatility Warrant Master Fund Ltd. and other parties",
"Form of the Subordinated Convertible Promissory Note"
09/20/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
08/23/2022 8-K Other Events  Interactive Data
07/12/2022 8-K Quarterly results
06/28/2022 8-K Quarterly results
05/13/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy